Position in NVS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$283,193
+$57,429 QoQ
Shares Held
1,807
+22.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,165
of 1,603 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Red Door Wealth Management, LLC holds $54,600,092 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
117,172 | $15,056,602 | |
| 2 | AMGN |
Amgen Inc
|
34,111 | $12,352,275 | |
| 3 | ABBV |
AbbVie Inc.
|
48,414 | $12,182,898 | |
| 4 | JNJ |
Johnson & Johnson
|
29,210 | $7,418,463 | |
| 5 | LLY |
ELI LILLY & Co
|
3,342 | $4,008,495 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
16,247 | $936,152 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,264 | $791,393 | |
| 8 | NVO |
Novo Nordisk A S
|
14,577 | $698,821 |
All Filings in NVS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $283,193 | 1,807 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $225,764 | 1,478 | Shares | Sole | 2026-04-22 | |
| 2021-06-30 | $57,846 | 634 | Shares | Sole | 2021-07-29 | |
| 2020-06-30 | $21,136 | 242 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $19,952 | 242 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||